Deletion of a single β-catenin allele in osteocytes abolishes the bone anabolic response to loading

Journal of Bone and Mineral Research

Volumn 29, Issue 3, 2014, Pages 705-715

  Javaheri, Behzad ^a   Stern, Amber Rath ^b,c,d   Lara, Nuria ^b   Dallas, Mark ^b   Zhao, Hong ^b   Liu, Ying ^b   Bonewald, Lynda F ^b   Johnson, Mark L ^b  

^a ROYAL VETERINARY COLLEGE   (United Kingdom)

^b UNIVERSITY OF MISSOURI KANSAS CITY SCHOOL OF DENTISTRY   (United States)

^c UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^d Engineering Systems Incorporated   (United States)

Author keywords

catenin; bone formation; mechanical loading; osteocyte

Indexed keywords

BONE FORMATION; MECHANICAL LOADING; OSTEOCYTE; Β-CATENIN;

ALLELES; ANIMALS; BETA CATENIN; BONE DEVELOPMENT; FEMALE; MALE; MICE; MICE, KNOCKOUT; OSTEOCYTES;

EID: 84894467000     PISSN: 08840431     EISSN: 15234681     Source Type: Journal    
DOI: 10.1002/jbmr.2064     Document Type: Article

References (54)

1. Gong Y, Slee RB, Fukai N, et al. LDL Receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell. 2001; 107: 513-23.
2. Little RD, Carulli JP, Del Mastro RG, et al. A mutation in the LDL receptor-related protein 5 gene results in the autosomal dominant high-bone-mass trait. Am J Hum Genet. 2002; 70 (1): 11-9.
3. Boyden LM, Mao J, Belsky J, et al. High bone density due to a mutation in LDL-receptor-related protein 5. N Engl J Med. 2002; 346: 1513-21.
4. Johnson ML, Picconi JL, Recker RR., The gene for high bone mass. Endocrinologist. 2002; 12: 445-53.
5. Akhter MP, Wells DJ, Short SJ, et al. Bone biomechanical properties in LRP5 mutant mice. Bone. 2004; 35 (1): 162-9.
6. Johnson ML., The high bone mass family-the role of wnt/LRP5 signaling in the regulation of bone mass. J Mus Neuron Interact. 2004; 4 (2): 135-8.
7. Hens JR, Wilson KM, Dann P, Chen X, Horowitz MC, Wysolmerski JJ., TOPGAL mice show that the canonical Wnt signaling pathway is active during bone development and growth and is activated by mechanical loading in vitro. J Bone Miner Res. 2005; 20: 1103-13.
8. Sawakami K, Robling AG, Ai M, et al. The Wnt co-receptor Lrp5 is essential for skeletal mechanotransduction, but not for the anabolic bone response to parathyroid hormone treatment. J Biol Chem. 2006; 281: 23698-711.
9. Lau K-HW, Kapur S, Kesavan C, Baylink DJ., Up-regulation of the Wnt, estrogen receptor, insulin-like growth factor-I, and bone morphogenetic protein pathways in C57BL/6J osteoblasts as opposed to C3H/HeJ osteoblasts in part contributes to the differential anabolic response to fluid shear. J Biol Chem. 2006; 281: 9576-88.
10. Robinson JA, Chatterjee-Kishore M, Yaworsky P, et al. Wnt/b-catenin signaling is a normal physiological response to mechanical loading in bone. J Biol Chem. 2006; 281: 31720-8.
11. Armstrong VJ, Muzylak M, Sunters A, et al. Wnt/b-catenin signaling is a component of osteoblastic bone cell early responses to load-bearing and requires estrogen receptor a. J Biol Chem. 2007; 282: 20715-27.
12. Armstrong VJ, Muzylak M, Sunters A, et al. Estrogen receptor a is required for strain-related b-catenin signaling in osteoblasts. J Bone Miner Res. 2007; 22 (suppl 1):S95 (abstr S064).
13. Kamel MA, Picconi JL, Lara-Castillo N, Johnson ML., Activation of beta-catenin signaling in MLO-Y4 osteocytic cells versus 2T3 osteoblastic cells by fluid flow shear stress and PGE(2): implications for the study of mechanosensation in bone. Bone. 2010; 47 (5): 872-81.
14. Santos A, Bakker AD, Zandieh-Doulabi B, de Blieck-Hogervorst JM, Klein-Nulend J., Early activation of the beta-catenin pathway in osteocytes is mediated by nitric oxide, phosphatidyl inositol-3 kinase/Akt, and focal adhesion kinase. Biochem Biophys Res Commun. 2010; 391 (1): 364-9.
15. Saxon LK, Jackson BF, Sugiyama T, Lanyon LE, Price JS., Analysis of multiple bone responses to graded strains above functional levels, and to disuse, in mice in vivo show that the human Lrp5 G171V high bone mass mutation increases the osteogenic response to loading but that lack of Lrp5 activity reduces it. Bone. 2011; 49 (2): 184-93.
16. Bonewald LF, Johnson ML., Osteocytes, mechanosensing and Wnt signaling. Bone. 2008; 42: 606-15.
17. Sunters A, Armstrong VJ, Zaman G, et al. Mechano-transduction in osteoblastic cells involves strain-regulated estrogen receptor a-mediated control of insulin-like growth factor (IGF) I receptor sensitivity to ambient IGF, leading to phosphatidylinositol 3-kinase/AKT-dependent Wnt/LRP5 receptor-independent activation of beta-catenin signaling. J Biol Chem. 2010; 285 (12): 8743-58.
18. Reya T, Clevers H., Wnt signalling in stem cells and cancer. Nature. 2005; 434: 843-50.
19. Kato M, Patel MS, Levasseur R, et al. Cbfa 1-independent decrease in osteoblast proliferation, osteopenia, and persistent embryonic eye vascularization in mice deficient in Lrp5, a Wnt coreceptor. J Cell Biol. 2002; 157: 303-14.
20. Bodine PVN, Zhao W, Kharode YP, et al. The Wnt antagonist secreted frizzled-related protein-1 is a negative regulator of trabecular bone formation in adult mice. Mol Endocrinol. 2004; 18: 1222-37.
21. Babij P, Zhao W, Small C, et al. High bone mass in mice expressing a mutant LRP5 gene. J Bone Miner Res. 2003; 18: 960-74.
22. Glass DA, Bialek P, Ahn JD, et al. Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation. Dev Cell. 2005; 8: 751-64.
23. Holmen SL, Zylstra CR, Mukherjee A, et al. Essential role of b-catenin in postnatal bone acquisition. J Biol Chem. 2005; 280: 21162-8.
24. Kramer I, Halleux C, Keller H, et al. Osteocyte Wnt/b-catenin signaling is required for normal bone homeostasis. Mol Cell Biol. 2010; 30: 3071-85.
25. Nakashima T, Hayashi M, Fukunaga T, et al. Evidence for osteocyte regulation of bone homeostasis through RANKL expression. Nat Med. 2011; 17 (10): 1231-4.
26. Wijenayaka AR, Kogawa M, Lim HP, Bonewald LF, Findlay DM, Atkins GJ., Sclerostin stimulates osteocyte support of osteoclast activity by a RANKL-dependent pathway. PLOS ONE. 2011; 6 (10): e25900.
27. Xiong J, Onal M, Jilka RL, Weinstein RS, Manolagas SC, O'Brien CA., Matrix-embedded cells control osteoclast formation. Nat Med. 2011; 17 (10): 1235-41.
28. Lu Y, Xie Y, Zhang S, Dusevich V, Bonewald LF, Feng JQ., DMP1-targeted Cre expression in odontoblasts and osteocytes. J Dent Res. 2007; 86 (4): 320-5.
29. Dempster DW, Compston JE, Drezner MK, et al. Standardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res. 2013; 28 (1): 2-17.
30. Bouxsein ML, Boyd SK, Christiansen BA, Guldberg RE, Jepsen KJ, Müller R., Guidelines for assessment of bone microstructure in rodents using micro-computed tomography. J Bone Miner Res. 2010; 25 (7): 1468-86.
31. Korecki C, Zinser G, Liu X, Siedler J, Welsh J, Niebur G., Effect of the Vitamin D receptor on bone geometry and strength during gestation and lactation in mice. Calcif Tissue Int. 2009; 85 (5): 405-11.
32. Doube M, Kłosowski MM, Arganda-Carreras I, Cordelières FP, et al. BoneJ: free and extensible bone image analysis in ImageJ. Bone. 2010; 47 (6): 1076-9.
33. Schneider CA, Rasband WS, Eliceri KW., NIH IMage to ImageJ: 25 years of image analysis. Nat Methods. 2012; 9: 671-5.
34. Yao W, Cheng Z, Shahnazari M, Dai W, Johnson ML, Lane NE., Overexpression of secreted frizzled-related protein 1 inhibits bone formation and attenuates parathyroid hormone bone anabolic effects. J Bone Miner Res. 2010; 25 (2): 190-9.
35. Diarra D, Stolina M, Polzer K, et al. Dickkopf-1 is a master regulator of joint remodeling. Nat Med. 2007; 13: 156-63.
36. Li X, Ominsky MS, Niu Q-T, et al. Targeted deletion of the sclerostin gene in mice results in increased bone formation and bone strength. J Bone Miner Res. 2008; 23 (6): 860-9.
37. Javaheri B, Sunters A, Zaman G, et al. Lrp5 is not required for the proliferative response of osteoblasts to strain but regulates proliferation,apoptosis in a cell autonomous manner. PLOS ONE. 2012; 7 (5): e35726.
38. Galea GL, Meakin LB, Sugiyama T, et al. Estrogen receptor α mediates proliferation of osteoblastic cells stimulated by estrogen and mechanical strain, but their acute down-regulation of the Wnt antagonist sost is mediated by estrogen receptor β. J Biol Chem. 2013; 288 (13): 9035-48.
39. Xing W, Baylink D, Kesavan C, et al. Global gene expression analysis in the bones reveals involvement of several novel genes and pathways in mediating an anabolic response of mechanical loading in mice. J Cell Biochem. 2005; 96 (5): 1049-60.
40. Johnson ML., LRP5 and bone mass regulation: where are we now ? BoneKEy Rep. 2012; 1: 1-6.
41. Pinson KI, Brennan J, Monkley S, Avery BJ, Skarnes WC., An LDL-receptor-related protein mediates Wnt signalling in mice. Nature. 2000; 407: 535-8.
42. Holmen SL, Giambernardi TA, Zylstra CR, et al. Decreased BMD and limb deformities in mice carrying mutations in both Lrp5 and Lrp6. J Bone Miner Res. 2004; 19: 2033-40.
43. Choi HY, Dieckmann M, Herz J, Niemeier A., Lrp4, a novel receptor for dickkopf 1 and sclerostin, is expressed by osteoblasts and regulates bone growth and turnover in vivo. PLOS ONE. 2009; 4 (11): e7930.
44. Dallas SL, Prideaux M, Bonewald LF., The osteocyte: an endocrine cell and more. Endocrine Rev. 2013 Apr 26. [Epub ahead of print].
45. Kitase Y, Barragan L, Jiang JX, Johnson ML, Bonewald LF., Mechanical induction of PGE(2) in osteocytes blocks glucocorticoid induced apoptosis through both the beta-catenin and PKA pathways. J Bone Miner Res. 2010; 25 (12): 2657-68.
46. Sen B, Styner M, Xie Z, Case N, Rubin CT, Rubin J., Mechanical loading regulates NFATc1 and beta-catenin signaling through a GSK3beta control node. J Biol Chem. 2009; 284 (50): 34607-17.
47. Case N, Ma M, Sen B, Xie Z, Gross TS, Rubin J., Beta-catenin levels influence rapid mechanical responses in osteoblasts. J Biol Chem. 2008; 283 (43): 29196-205.
48. Srivastava T, McCarthy ET, Sharma R, et al. Prostaglandin E2 is crucial in the response of podocytes to fluid flow shear stress. J Cell Commun Signal. 2010; 4 (2): 79-90.
49. Monga SPS., Role of Wnt/β-catenin signaling in liver metabolism and cancer. Int J Biochem Cell Biol. 2011; 43 (7): 1021-9.
50. Nathke I., Cytoskeleton out of the cupboard: colon cancer and cytoskeletal changes induced by loss of APC. Nat Rev Cancer. 2006; 6 (12): 967-74.
51. Polakis P., Wnt signaling and cancer. Gene Dev. 2000; 14: 1837-51.
52. Logan CY, Nusse R., The Wnt Signaling pathway in development and disease. Annu Rev Cell Dev Biol. 2004; 20: 781-810.
53. Nusse R., Wnt signaling in disease and development. Cell Res. 2005; 15: 28-32.
54. Bodine PVN, Komm BS., Wnt signaling and osteoblastogenesis. Rev Endocrine Metab Disord. 2006; 7: 33-9.